Azapropazone

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Azapropazone is a non-steroidal anti-inflammatory drug. It is manufactured by Goldshield under the tradename Rheumox.^[1]

It was available in the UK as a prescription-only drug, with restrictions due to certain contra-indications and side-effects.^[2] Azopropazone has now been discontinued in the British National Formulary.

Azapropazone has a half-life of approximately 20 hours in humans and is not extensively metabolized.^[3]

References

↑ http://home.intekom.com/pharm/cont_eth/rheumox.html
↑ http://www.patient.co.uk/showdoc/30002267/
↑ Jones CJ (1976). “The pharmacology and pharmacokinetics of azapropazone – a review”. Curr Med Res Opin. 4 (1): 3–16. doi:10.1185/03007997609109361. PMID 770078.

[1] ttp://home.intekom.com/pharm/cont_eth/rheumox.html

[2] ttp://www.patient.co.uk/showdoc/30002267/

[pmid770078-3] Jones CJ (1976). “The pharmacology and pharmacokinetics of azapropazone – a review”. Curr Med Res Opin. 4 (1): 3–16. doi:10.1185/03007997609109361. PMID 770078.

[1]

[2]

[3]